-
Why Luna Innovations Shares Are Gaining Today
Monday, May 16, 2022 - 8:54am | 225Luna Innovations Inc (NASDAQ: LUNA) reported first-quarter FY22 revenue growth of 7% year-on-year to $22.5 million, beating the consensus of $21.2 million. Margins: The gross margin expanded 600 bps to 64%, driven primarily by a favorable product mix. The operating margin...
-
10 Biggest Price Target Changes For Monday
Monday, May 16, 2022 - 7:53am | 411Needham cut the price target on Carvana Co. (NYSE: CVNA) from $121 to $80. Carvana shares rose 11.3% to $42.71 in pre-market trading. Susquehanna cut Taboola.com Ltd. (NASDAQ: TBLA) price target from $10 to $3.5. Taboola.com shares fell 3% to $3.25 in pre-market trading. Wedbush raised the...
-
30 Stocks Moving in Monday's Pre-Market Session
Monday, May 16, 2022 - 6:57am | 1074Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) rose 25.2% to $2.09 in pre-market trading after gaining around 10% on Friday. ShiftPixy, Inc. (NASDAQ: PIXY) rose 21.5% to $0.6198 in pre-market trading after jumping 155% on Friday. Calyxt, Inc. (NASDAQ: CLXT) shares rose 21.4% to $0.4198 in...
-
10 Biggest Price Target Changes For Monday
Monday, May 9, 2022 - 8:47am | 414Morgan Stanley cut Guardant Health, Inc. (NASDAQ: GH) price target from $120 to $85. Guardant Health shares rose 4.3% to $40.99 in pre-market trading. Oppenheimer cut the price target for Relmada Therapeutics, Inc. (NASDAQ: RLMD) from $75 to $64. Relmada Therapeutics shares fell 5.2% to close...
-
Walgreens Announces $683M Opioid Settlement With Florida
Thursday, May 5, 2022 - 3:30pm | 389Walgreens Boots Alliance Inc (NASDAQ: WBA) has reached a $683 million settlement with Florida to resolve claims that the pharmacy chain exacerbated an opioid epidemic in the state. The settlement includes $620 million to be paid to Florida over 18 years, plus $63 million for legal...
-
Turning Point Inks Licensing Pact For Gastrointestinal Cancers Candidate
Thursday, May 5, 2022 - 3:28pm | 276Turning Point Therapeutics Inc (NASDAQ: TPTX) entered into an exclusive license agreement with LaNova Medicines Limited to develop and commercialize LM-302, in the U.S. and the rest of the world, excluding Greater China and South Korea. LM-302 is a novel antibody-...
-
A Peek Into The Markets: US Stock Futures Down Following Wednesday's Surge
Thursday, May 5, 2022 - 5:34am | 809Pre-open movers U.S. stock futures traded lower in early pre-market trade. The Dow Jones gained more than 900 points in the previous session following an interest rate hike from the Federal Reserve. Investors are awaiting earnings results from ConocoPhillips (NYSE: COP), McKesson Corporation (...
-
5 Stocks To Watch For May 5, 2022
Thursday, May 5, 2022 - 4:26am | 264Some of the stocks that may grab investor focus today are: Wall Street expects ConocoPhillips (NYSE: COP) to report quarterly earnings at $3.00 per share on revenue of $16.50 billion before the opening bell. ConocoPhillips shares rose 0.3% to $104.14 in after-hours trading. eBay Inc. (NASDAQ:...
-
Masimo Posts Better Than Expected Q1 Earnings Despite 'Unexpected' Supply Chain Issues
Wednesday, May 4, 2022 - 11:21am | 300Masimo Corp's (NASDAQ: MASI) Q1 revenue increased 1.7% Y/Y (+3.2% on a constant currency basis) to $304.2 million, beating the consensus of $303.83 million. Excluding handheld and fingertip pulse oximeters, shipments of noninvasive technology boards and instruments were 75,700...
-
20 Stocks Moving in Monday's Pre-Market Session
Monday, May 2, 2022 - 7:52am | 728Gainers SoundHound AI, Inc. (NASDAQ: SOUN) rose 64.3% to $10.68 in pre-market trading after tumbling 13% on Friday. SoundHound had their IPO on Thursday. Better Therapeutics, Inc. (NASDAQ: BTTX) shares rose 53.5% to $1.40 in pre-market trading following a 5% drop on Friday. Luokung Technology...
-
San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters
Monday, April 25, 2022 - 4:11pm | 442San Francisco will start a trial against Walgreens Boots Alliance Inc (NASDAQ: WBA) and three other companies accused of fueling an opioid crisis in the city. San Francisco has alleged that Walgreens, Teva Pharmaceutical Industries Ltd (NYSE: TEVA), AbbVie Inc's (...
-
JNJ, McKesson, Endo Settle $275M Opioid Claims With Alabama: Reuters
Wednesday, April 20, 2022 - 3:51pm | 394Alabama reached $276 million in settlements with Johnson & Johnson (NYSE: JNJ), McKesson Corporation (NYSE: MCK), and Endo International Plc (NASDAQ: ENDP), resolving claims on the opioid addiction crisis, the state attorney general said. McKesson will...
-
Turning Point Reveals Topline Data From Pivotal Repotrectinib Trial In Lung Cancer Setting
Wednesday, April 13, 2022 - 7:40am | 343Turning Point Therapeutics Inc (NASDAQ: TPTX) announced topline results from the registrational TRIDENT-1 study of repotrectinib across all four ROS1-positive advanced non-small cell lung cancer (NSCLC) cohorts. In a total of 71 TKI-naïve advanced NSCLC population, the...
-
West Virginia Says J&J, Teva, AbbVie Caused 'Tsunami' Of Opioid Addiction: Reuters
Monday, April 4, 2022 - 3:09pm | 449West Virginia's attorney general urged a judge to hold Johnson & Johnson (NYSE: JNJ), Teva Pharmaceuticals Industries Ltd (NYSE: TEVA), and AbbVie Inc's (NYSE: ABBV) Allergen accountable for causing a "tsunami" of opioid addiction in the...
-
Lexicon Touts New Favorable Data On Sotaglifozin Cardio Data
Monday, April 4, 2022 - 9:15am | 269At the American College of Cardiology, Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) highlighted a new data analysis from the SCORED Phase 3 trial of sotagliflozin in Type 2 diabetes and kidney disease patients. Sotagliflozin significantly reduced major adverse cardiovascular...